Lowering the plasma fibrinogen concentration with drugs. 1992

E Ernst
Department of Physical Medicine and Rehabilitation, University of Vienna, Austria.

UI MeSH Term Description Entries
D001778 Blood Coagulation Disorders Hemorrhagic and thrombotic disorders that occur as a consequence of abnormalities in blood coagulation due to a variety of factors such as COAGULATION PROTEIN DISORDERS; BLOOD PLATELET DISORDERS; BLOOD PROTEIN DISORDERS or nutritional conditions. Coagulation Disorders, Blood,Disorders, Blood Coagulation,Blood Coagulation Disorder,Coagulation Disorder, Blood,Disorder, Blood Coagulation
D005340 Fibrinogen Plasma glycoprotein clotted by thrombin, composed of a dimer of three non-identical pairs of polypeptide chains (alpha, beta, gamma) held together by disulfide bonds. Fibrinogen clotting is a sol-gel change involving complex molecular arrangements: whereas fibrinogen is cleaved by thrombin to form polypeptides A and B, the proteolytic action of other enzymes yields different fibrinogen degradation products. Coagulation Factor I,Factor I,Blood Coagulation Factor I,gamma-Fibrinogen,Factor I, Coagulation,gamma Fibrinogen
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

E Ernst
January 1983, Laboratornoe delo,
E Ernst
February 1992, Cardiovascular drugs and therapy,
E Ernst
November 1984, Polski tygodnik lekarski (Warsaw, Poland : 1960),
E Ernst
January 1981, American journal of veterinary research,
E Ernst
June 1985, Atherosclerosis,
E Ernst
June 1969, The American journal of physiology,
Copied contents to your clipboard!